These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29414807)

  • 1. Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer.
    Zhang J; Zhang J; Xu S; Zhang X; Wang P; Wu H; Xia B; Zhang G; Lei B; Wan L; Zhang D; Pang D
    Cell Physiol Biochem; 2018; 45(2):692-705. PubMed ID: 29414807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
    Huang L; Ao Q; Zhang Q; Yang X; Xing H; Li F; Chen G; Zhou J; Wang S; Xu G; Meng L; Lu Y; Ma D
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):447-56. PubMed ID: 19760195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
    Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
    Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATIP3 deficiency facilitates intracellular accumulation of paclitaxel to reduce cancer cell migration and lymph node metastasis in breast cancer patients.
    Rodrigues-Ferreira S; Nehlig A; Kacem M; Nahmias C
    Sci Rep; 2020 Aug; 10(1):13217. PubMed ID: 32764625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.
    Jin Y; Hu W; Liu T; Rana U; Aguilera-Barrantes I; Kong A; Kumar SN; Wang B; Gao P; Wang X; Duan Y; Shi A; Song D; Yang M; Li S; Han B; Zhao G; Fan Z; Miao QR
    Cancer Lett; 2018 Apr; 419():233-244. PubMed ID: 29373839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
    Sun S; Liang X; Zhang X; Liu T; Shi Q; Song Y; Jiang Y; Wu H; Jiang Y; Lu X; Pang D
    Br J Cancer; 2015 Apr; 112(8):1332-9. PubMed ID: 25867275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropomyosin 2 exerts anti-tumor effects in lung adenocarcinoma and is a novel prognostic biomarker.
    Duan P; Cui J; Li H; Yuan L
    Histol Histopathol; 2023 Jun; 38(6):669-680. PubMed ID: 36102257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.
    Cui J; Cai Y; Hu Y; Huang Z; Luo Y; Kaz AM; Yang Z; Chen D; Fan X; Grady WM; Wang J
    Tumour Biol; 2016 Sep; 37(9):12477-12483. PubMed ID: 27333992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
    Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
    Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer.
    Zhou X; Li Z; Chen H; Jiao M; Zhou C; Li H
    Int J Gen Med; 2024; 17():59-74. PubMed ID: 38221941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
    Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
    Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
    Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
    McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
    BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
    Zhao Y; Wei L; Liu J; Li F
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
    Cheng GZ; Chan J; Wang Q; Zhang W; Sun CD; Wang LH
    Cancer Res; 2007 Mar; 67(5):1979-87. PubMed ID: 17332325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
    Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
    Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2.
    Ni X; Xia T; Zhao Y; Zhou W; Wu N; Liu X; Ding Q; Zha X; Sha J; Wang S
    Cancer Sci; 2014 Jan; 105(1):18-25. PubMed ID: 24164962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.
    Yang YF; Lee YC; Wang YY; Wang CH; Hou MF; Yuan SF
    Kaohsiung J Med Sci; 2019 Jul; 35(7):408-416. PubMed ID: 31001932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.